|
1
|
Van Diest PJ, van der Wall E and Baak JP:
Prognostic value of proliferation in invasive breast cancer: A
review. J Clin Pathol. 57:675–681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu H, Yang J, Jiao S, Li Y, Li L and Wang
J: A proliferation-inducing ligand expression in breast cancer and
its relationship with prognosis. Nan Fang Yi Ke Da Xue Xue Bao.
35:185–190. 2015.(In Chinese). PubMed/NCBI
|
|
3
|
Wu X, Zeng R, Wu S, Zhong J, Yang L and Xu
J: Comprehensive expression analysis of miRNA in breast cancer at
the miRNA and isomiR levels. Gene. 557:195–200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xue J, Chi Y, Chen Y, Huang S, Ye X, Niu
J, Wang W, Pfeffer LM, Shao ZM, Wu ZH and Wu J: MiRNA-621
sensitizes breast cancer to chemotherapy by suppressing FBXO11 and
enhancing p53 activity. Oncogene. 35:448–458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zaleska K: miRNA - Therapeutic tool in
breast cancer? Where are we now? Rep Pract Oncol Radiother.
20:79–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fiannaca A, La Rosa M, La Paglia L, Rizzo
R and Urso A: Analysis of miRNA expression profiles in breast
cancer using biclustering. BMC Bioinformatics. 16 Suppl 4:S72015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McGuire A, Brown JA and Kerin MJ:
Metastatic breast cancer: The potential of miRNA for diagnosis and
treatment monitoring. Cancer Metastasis Rev. 34:145–155. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le XF, Almeida MI, Mao W, Spizzo R, Rossi
S, Nicoloso MS, Zhang S, Wu Y, Calin GA and Bast RC Jr: Modulation
of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in
breast cancer. PLoS One. 7:e411702012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iizuka D, Imaoka T, Nishimura M, Kawai H,
Suzuki F and Shimada Y: Aberrant microRNA expression in
radiation-induced rat mammary cancer: The potential role of miR-194
overexpression in cancer cell proliferation. Radiat Res.
179:151–159. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujii Y, Yada M, Nishiyama M, Kamura T,
Takahashi H, Tsunematsu R, Susaki E, Nakagawa T, Matsumoto A and
Nakayama KI: Fbxw7 contributes to tumor suppression by targeting
multiple proteins for ubiquitin-dependent degradation. Cancer Sci.
97:729–736. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koepp DM, Schaefer LK, Ye X, Keyomarsi K,
Chu C, Harper JW and Elledge SJ: Phosphorylation-dependent
ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.
Science. 294:173–177. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moberg KH, Bell DW, Wahrer DC, Haber DA
and Hariharan IK: Archipelago regulates Cyclin E levels in
Drosophila and is mutated in human cancer cell lines. Nature.
413:311–316. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Strohmaier H, Spruck CH, Kaiser P, Won KA,
Sangfelt O and Reed SI: Human F-box protein hCdc4 targets cyclin E
for proteolysis and is mutated in a breast cancer cell line.
Nature. 413:316–322. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Welcker M, Orian A, Jin J, Grim JE, Harper
JW, Eisenman RN and Clurman BE: The Fbw7 tumor suppressor regulates
glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein
degradation. Proc Natl Acad Sci USA. 101:pp. 9085–9090. 2004;
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yada M, Hatakeyama S, Kamura T, Nishiyama
M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K and
Nakayama KI: Phosphorylation-dependent degradation of c-Myc is
mediated by the F-box protein Fbw7. EMBO J. 23:2116–2125. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao JH, Perez-Losada J, Wu D, Delrosario
R, Tsunematsu R, Nakayama KI, Brown K, Bryson S and Balmain A:
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor
gene. Nature. 432:775–779. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hubbard EJ, Wu G, Kitajewski J and
Greenwald I: sel-10, a negative regulator of lin-12 activity in
Caenorhabditis elegans, encodes a member of the CDC4 family of
proteins. Genes Dev. 11:3182–3193. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta-Rossi N, Le Bail O, Gonen H, Brou C,
Logeat F, Six E, Ciechanover A and Israël A: Functional interaction
between SEL-10, an F-box protein, and the nuclear form of activated
Notch1 receptor. J Biol Chem. 276:34371–34378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oberg C, Li J, Pauley A, Wolf E, Gurney M
and Lendahl U: The Notch intracellular domain is ubiquitinated and
negatively regulated by the mammalian Sel-10 homolog. J Biol Chem.
276:35847–35853. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu G, Lyapina S, Das I, Li J, Gurney M,
Pauley A, Chui I, Deshaies RJ and Kitajewski J: SEL-10 is an
inhibitor of notch signaling that targets notch for
ubiquitin-mediated protein degradation. Mol Cell Biol.
21:7403–7415. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nateri AS, Riera-Sans L, Da Costa C and
Behrens A: The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK
signaling. Science. 303:1374–1378. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Balamurugan K, Wang JM, Tsai HH, Sharan S,
Anver M, Leighty R and Sterneck E: The tumour suppressor C/EBPδ
inhibits FBXW7 expression and promotes mammary tumour metastasis.
EMBO J. 29:4106–4117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu L, Balasubramanian M, Shan J,
Dudenhausen EE and Kilberg MS: Auto-activation of c-JUN gene by
amino acid deprivation of hepatocellular carcinoma cells reveals a
novel c-JUN-mediated signaling pathway. J Biol Chem.
286:36724–36738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Snijders AM, Liu Y, Su L, Huang Y and Mao
JH: Expression profiling reveals transcriptional regulation by
Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Oncotarget. 6:44794–44805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hernandez MA, Patel B, Hey F, Giblett S,
Davis H and Pritchard C: Regulation of BRAF protein stability by a
negative feedback loop involving the MEK-ERK pathway but not the
FBXW7 tumour suppressor. Cell Signal. 28:561–571. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Akhoondi S, Lindström L, Widschwendter M,
Corcoran M, Bergh J, Spruck C, Grandér D and Sangfelt O:
Inactivation of FBXW7/hCDC4-β expression by promoter
hypermethylation is associated with favorable prognosis in primary
breast cancer. Breast Cancer Res. 12:R1052010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Guo Y, Liang X, Sun M, Wang G, De W
and Wu W: MicroRNA-223 functions as an oncogene in human gastric
cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol.
138:763–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lewis BP, Shih I-H, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen P and Yao GD: The role of cullin
proteins in gastric cancer. Tumor Biol. 37:29–37. 2016. View Article : Google Scholar
|
|
31
|
Wu XZ, Wang KP, Song HJ, Xia JH, Jiang Y
and Wang YL: MiR-27a-3p promotes esophageal cancer cell
proliferation via F-box and WD repeat domain-containing 7 (FBXW7)
suppression. Int J Clin Exp Med. 8:15556–15562. 2015.PubMed/NCBI
|
|
32
|
Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ,
Wang TY, Li HC and Wu XN: Differential expression of miRNAs in
esophageal cancer tissue. Oncol Lett. 5:1639–1642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tanić M, Yanowski K, Andrés E, Gómez-López
G, Socorro MR, Pisano DG, Martinez-Delgado B and Benítez J: miRNA
expression profiling of formalin-fixed paraffin-embedded (FFPE)
hereditary breast tumors. Genom Data. 3:75–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu J, Xu J, Wu Y, Chen Q, Zheng W, Lu X,
Zhou C and Jiao D: Identification of microRNA-93 as a functional
dysregulated miRNA in triple-negative breast cancer. Tumour Biol.
36:251–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu Z, Wang P, Song C, Wang K, Yan R, Li J
and Dai L: Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1,
RAD51 and RAD52 involved in HRR pathway genes and risk of breast
cancer in China. Mol Genet Genomics. 290:1141–1153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang W, Qian P, Zhang X, Zhang M, Wang H,
Wu M, Kong X, Tan S, Ding K, Perry JK, et al: Autocrine/paracrine
human growth hormone-stimulated MicroRNA 96-182-183 cluster
promotes epithelial-mesenchymal transition and invasion in breast
cancer. J Biol Chem. 290:13812–13829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove
R, Xu R and Huang W: miR-194 is a marker of hepatic epithelial
cells and suppresses metastasis of liver cancer cells in mice.
Hepatology. 52:2148–2157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song Y, Zhao F, Wang Z, Liu Z, Chiang Y,
Xu Y, Gao P and Xu H: Inverse association between miR-194
expression and tumor invasion in gastric cancer. Ann Surg Oncol. 19
Suppl 3:S509–S517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen X, Wang Y, Zang W, Du Y, Li M and
Zhao G: miR-194 targets RBX1 gene to modulate proliferation and
migration of gastric cancer cells. Tumour Biol. 36:2393–2401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khella HW, Bakhet M, Allo G, Jewett MA,
Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA and Yousef
GM: miR-192, miR-194 and miR-215: A convergent microRNA network
suppressing tumor progression in renal cell carcinoma.
Carcinogenesis. 34:2231–2239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y,
Liu QH, Shi M, Ni CR and Zhu MH: Upregulation of miR-194
contributes to tumor growth and progression in pancreatic ductal
adenocarcinoma. Oncol Rep. 31:1157–1164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yokobori T, Mimori K, Iwatsuki M, Ishii H,
Onoyama I, Fukagawa T, Kuwano H, Nakayama KI and Mori M:
p53-Altered FBXW7 expression determines poor prognosis in gastric
cancer cases. Cancer Res. 69:3788–3794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Iwatsuki M, Mimori K, Ishii H, Yokobori T,
Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H and Mori
M: Loss of FBXW7, a cell cycle regulating gene, in colorectal
cancer: Clinical significance. Int J Cancer. 126:1828–1837.
2010.PubMed/NCBI
|
